home > drugs a-z list > rebetron (rebetol and intron a combination therapy) drug center

Recommended Topic Related To:

Rebetron

Hepatitis C infection facts

  • HCV is one of several viruses that cause hepatitis (inflammation of the liver).
  • Up to 85% of individuals who are initially (acutely) infected with HCV will fail to eliminate the virus and will become chronically infected.
  • HCV is spread most commonly through inadvertent exposure to infected blood. Intravenous drug abuse is the most common mode of transmission. The risk of acquiring HCV through sexual contact is low.
  • Generally, patients do not develop symptoms of chronic infection with HCV until they have extensive scarring of the liver (cirrhosis). Some individuals, however, may have fatigue and other non-specific symptoms in the absence of cirrhosis. A minority of patients with HCV have symptoms from organs outside of the liver.
  • In the U.S., Infection with HCV is the most common cause of chronic hepatitis and the most common reason for liver transplantation.
  • ...

Rebetron

font size

Rebetron Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Rebetron Prescribing Information: Indications & Dosage

REBETOL (ribavirin) Structural Formula Illustration

REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with alpha interferon or who have relapsed following alpha interferon therapy.

Read the complete drug monograph for Rebetron »

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.